Rhythm Pharmaceuticals Stock Market Value
| RYTM Stock | USD 103.64 0.97 0.94% |
| Symbol | Rhythm |
Will Biotechnology sector continue expanding? Could Rhythm diversify its offerings? Factors like these will boost the valuation of Rhythm Pharmaceuticals. Anticipated expansion of Rhythm directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Rhythm Pharmaceuticals data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (3.10) | Revenue Per Share | Quarterly Revenue Growth 0.543 | Return On Assets | Return On Equity |
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Rhythm Pharmaceuticals' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Rhythm Pharmaceuticals should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Rhythm Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Rhythm Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Rhythm Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Rhythm Pharmaceuticals.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Rhythm Pharmaceuticals on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Rhythm Pharmaceuticals or generate 0.0% return on investment in Rhythm Pharmaceuticals over 90 days. Rhythm Pharmaceuticals is related to or competes with Revolution Medicines, Avidity Biosciences, Protagonist Therapeutics, Stoke Therapeutics, Uniqure NV, Rocket Pharmaceuticals, and Solid Biosciences. Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercializa... More
Rhythm Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Rhythm Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Rhythm Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 18.69 | |||
| Value At Risk | (5.14) | |||
| Potential Upside | 4.03 |
Rhythm Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Rhythm Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Rhythm Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Rhythm Pharmaceuticals historical prices to predict the future Rhythm Pharmaceuticals' volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | (0.06) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rhythm Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Rhythm Pharmaceuticals January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.05) | |||
| Mean Deviation | 2.42 | |||
| Coefficient Of Variation | (7,686) | |||
| Standard Deviation | 3.21 | |||
| Variance | 10.32 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | (0.06) | |||
| Maximum Drawdown | 18.69 | |||
| Value At Risk | (5.14) | |||
| Potential Upside | 4.03 | |||
| Skewness | 0.4659 | |||
| Kurtosis | 2.3 |
Rhythm Pharmaceuticals Backtested Returns
Rhythm Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0358, which implies the firm had a -0.0358 % return per unit of risk over the last 3 months. Rhythm Pharmaceuticals exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Rhythm Pharmaceuticals' Variance of 10.32, coefficient of variation of (7,686), and insignificant Risk Adjusted Performance to confirm the risk estimate we provide. The company holds a Beta of 0.92, which implies possible diversification benefits within a given portfolio. Rhythm Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Rhythm Pharmaceuticals is expected to follow. At this point, Rhythm Pharmaceuticals has a negative expected return of -0.12%. Please make sure to check Rhythm Pharmaceuticals' skewness and day typical price , to decide if Rhythm Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.21 |
Weak reverse predictability
Rhythm Pharmaceuticals has weak reverse predictability. Overlapping area represents the amount of predictability between Rhythm Pharmaceuticals time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Rhythm Pharmaceuticals price movement. The serial correlation of -0.21 indicates that over 21.0% of current Rhythm Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | -0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 21.46 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Rhythm Pharmaceuticals Correlation, Rhythm Pharmaceuticals Volatility and Rhythm Pharmaceuticals Alpha and Beta module to complement your research on Rhythm Pharmaceuticals. To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Rhythm Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.